Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inci Yildirim

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
American Journal of Epidemiology|August 7, 2024
Leveraging real-world data from administrative claims and medical records to inform safety and effectiveness of piperacillin-tazobactam in the management of pediatric hospital-acquired pneumoniaJesse A Blumenstock, Jennifer A Faerber, Muida Menon, et al.
The Journal of Infectious Diseases|July 19, 2023
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical TrialHana M El Sahly, Inci Yildirim, Sharon E Frey, et al.
The Lancet. Infectious Diseases|June 18, 2026
Neutralising antibody responses to MPXV clades Ia, Ib, and IIb after infection or vaccination: a multicountry observational studyJameson Crandell, Raianna F Fantin, Leonardo Pereira de Araújo, et al.
Nature|October 11, 2021
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunityCarolina Lucas, Chantal B F Vogels, Inci Yildirim, et al.
JAMA Network Open|August 6, 2025
All-Cause and Pneumococcal Community-Acquired Pneumonia Hospitalizations Among Adults in Tennessee and GeorgiaCarlos G Grijalva, Kelly D Johnson, J Jackson Resser, et al.
Science Immunology|May 5, 2023
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditisAnis Barmada, Jon Klein, Anjali Ramaswamy, et al.
Plos Biology|May 24, 2022
No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccinationAlice Lu-Culligan, Alexandra Tabachnikova, Eddy Pérez-Then, et al.
Emerging Infectious Diseases|December 23, 2024
Social Contact Patterns in Rural and Urban Settings, Mozambique, 2021-2022Moses C Kiti, Charfudin Sacoor, Obianuju G Aguolu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2023
Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older AdultsAshley Tippett, Gabby Ess, Laila Hussaini, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Lack of association between pandemic chilblains and SARS-CoV-2 infectionJeff R Gehlhausen, Alicia J Little, Christine J Ko, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
American Journal of Epidemiology|August 7, 2024
Leveraging real-world data from administrative claims and medical records to inform safety and effectiveness of piperacillin-tazobactam in the management of pediatric hospital-acquired pneumoniaJesse A Blumenstock, Jennifer A Faerber, Muida Menon, et al.
The Journal of Infectious Diseases|July 19, 2023
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical TrialHana M El Sahly, Inci Yildirim, Sharon E Frey, et al.
The Lancet. Infectious Diseases|June 18, 2026
Neutralising antibody responses to MPXV clades Ia, Ib, and IIb after infection or vaccination: a multicountry observational studyJameson Crandell, Raianna F Fantin, Leonardo Pereira de Araújo, et al.
Nature|October 11, 2021
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunityCarolina Lucas, Chantal B F Vogels, Inci Yildirim, et al.
JAMA Network Open|August 6, 2025
All-Cause and Pneumococcal Community-Acquired Pneumonia Hospitalizations Among Adults in Tennessee and GeorgiaCarlos G Grijalva, Kelly D Johnson, J Jackson Resser, et al.
Science Immunology|May 5, 2023
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditisAnis Barmada, Jon Klein, Anjali Ramaswamy, et al.
Plos Biology|May 24, 2022
No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccinationAlice Lu-Culligan, Alexandra Tabachnikova, Eddy Pérez-Then, et al.
Emerging Infectious Diseases|December 23, 2024
Social Contact Patterns in Rural and Urban Settings, Mozambique, 2021-2022Moses C Kiti, Charfudin Sacoor, Obianuju G Aguolu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2023
Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older AdultsAshley Tippett, Gabby Ess, Laila Hussaini, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Lack of association between pandemic chilblains and SARS-CoV-2 infectionJeff R Gehlhausen, Alicia J Little, Christine J Ko, et al.
Pageof 15